Sunday, April 11, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Utilization of Whole Genome Sequencing in Developing Countries

by Global Biodefense Staff
January 10, 2017
Whole Genome Sequencing

Whole Genome SequencingThe World Health Organization/Pan-American Health Organization (WHO/PAHO) is meeting this week on the application of Whole Genome Sequencing (WGS) as a tool to strengthen surveillance and response in developing countries.

Experts will convene from 10-13 January 2017 in Washington, D.C.to draft a road map offering practical advice to developing countries interested in implementing WGS as part of real-time surveillance and response systems.

WGS has the potential to change the way we detect, assess, investigate, manage, and monitor microbiological hazards and to improve the treatment of people suffering from infectious diseases. It allows for the identification and characterization of microorganisms with a level of specificity not previously possible.

The technology provides significant cross-sector potential, enabling uniform typing systems across animal, food and human sectors.

In developed countries, the use of WGS has primarily been in a research setting, but this is changing quickly as the cost of this technology and its associated methodologies drop. However, the implementation of WGS in developing countries to support their public health systems is not straightforward, and many challenges exist. It is likely that unnecessary effort and waste of limited resources will occur without international leadership and advice.

Source: WHO, adapted

Tags: Events

Related Posts

Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus
Biodetection

Duke University Develops Portable Diagnostic to Detect Early Biomarkers of Ebola Virus

April 7, 2021
CDC Awards $3 Billion in Wide-Reaching Campaign to Boost Vaccination Uptake
Policy + Initiatives

CDC Awards $3 Billion in Wide-Reaching Campaign to Boost Vaccination Uptake

April 7, 2021
How to Reduce PPE Facial Pressure Injuries in Frontline Health Care Workers
Public Health

How to Reduce PPE Facial Pressure Injuries in Frontline Health Care Workers

March 23, 2021
Technique for Testing Biosensor Materials Could Aid Noninvasive Diagnostic Development
Biodetection

Technique for Testing Biosensor Materials Could Aid Noninvasive Diagnostic Development

March 23, 2021
Load More

Latest News

A Virologist Explains Their Concerns About Coronavirus Variants

A Virologist Explains Their Concerns About Coronavirus Variants

April 8, 2021
What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

April 8, 2021
New Initiative to Support Studies of the Bat Immune System

New Initiative to Support Studies of the Bat Immune System

April 7, 2021
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

April 7, 2021

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe

© 2021 Stemar Media Group LLC